Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice

Vaccine

Volumn 32, Issue 18, 2014, Pages 2027-2033

  Gong, Wenping ^a   Xiong, Xiaolu ^a   Qi, Yong ^a   Jiao, Jun ^a   Duan, Changsong ^a   Wen, Bohai ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Adr2; Cell mediated immunity; Rickettsia rickettsii; Rocky Mountain spotted fever; Serum neutralization

Indexed keywords

ADR2 PROTEIN; BACTERIAL PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; RICKETTSIA VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; FEMALE; HUMORAL IMMUNITY; LIVER; LUNG; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SPLEEN;

ADR2; CELL-MEDIATED IMMUNITY; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SERUM NEUTRALIZATION.;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MICE; MICE, INBRED C3H; RECOMBINANT PROTEINS; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896544134     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.057     Document Type: Article

References (49)

1. Cobb J. The so-called spotted fever of the Rocky Mountains - a new disease in Bitter Root Valley, Mont. Public Health Reports (1896-1970) 1902, 1868-1870.
2. Wilson L.B., Chowning W.M. Studies in Pyroplasmosis hominis (spotted fever or tick fever of the Rocky Mountains) (with map, charts, and plates I, II). Journal of Infectious Diseases 1904, 1:31-57.
3. Eremeeva M.E., Zambrano M.L., Anaya L., Beati L., Karpathy S.E., Santos-Silva M.M., et al. Rickettsia rickettsii in Rhipicephalus ticks, Mexicali, Mexico. Journal of Medical Entomology 2011, 48:418-421.
4. Dahlgren F.S., Holman R.C., Paddock C.D., Callinan L.S., McQuiston J.H. Fatal Rocky Mountain Spotted Fever in the United States, 1999-2007. American Journal of Tropical Medicine and Hygiene 2012, 86:713.
5. Labruna M.B. Epidemiology of Brazilian spotted fever in the Atlantic Forest, state of São Paulo, Brazil 2012.
6. Angerami R.N., Câmara M., Pacola M.R., Rezende R., Duarte R.M., Nascimento E.M., et al. Features of Brazilian spotted fever in two different endemic areas in Brazil. Ticks and Tick-Borne Diseases 2012.
7. Parker R. Rocky Mountain spotted fever: results of fifteen years' prophylactic vaccination. American Journal of Tropical Medicine and Hygiene 1941, 1:369-383.
8. Cox H.R. Cultivation of Rickettsiae of the Rocky Mountain spotted fever, typhus and Q fever groups in the embryonic tissues of developing chicks. Science (New York, NY) 1941, 94:399.
9. Kenyon R.H., Pedersen C. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. Journal of Clinical Microbiology 1975, 1:500-503.
10. Diaz-Montero C., Feng H., Crocquet-Valdes P., Walker D. Identification of protective components of two major outer membrane proteins of spotted fever group Rickettsiae. American Journal of Tropical Medicine and Hygiene 2001, 65:371-378.
11. DuPont H., Hornick R., Dawkins A., Heiner G., Fabrikant I., Wisseman C., et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. Journal of Infectious Diseases 1973, 128:340-344.
12. Kenyon R.H., Kishimoto R., Hall W. Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine. Infection and Immunity 1979, 25:580-582.
13. Oster C.N., Burke D.S., Kenyon R.H., Ascher M.S., Harber P., Pedersen C.E. Laboratory-acquired Rocky Mountain spotted fever: the hazard of aerosol transmission. New England Journal of Medicine 1977, 297:859-863.
14. Li H., Walker D.H. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microbial Pathogenesis 1998, 24:289-298.
15. Uchiyama T., Kawano H., Kusuhara Y. The major outer membrane protein rOmpB of spotted fever group rickettsiae functions in the rickettsial adherence to and invasion of Vero cells. Microbes and Infection 2006, 8:801-809.
16. Riley S.P., Goh K.C., Hermanas T.M., Cardwell M.M., Chan Y.G., Martinez J.J. The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells. Infection and Immunity 2010, 78:1895-1904.
17. Cardwell M.M., Martinez J.J. The Sca2 autotransporter protein from Rickettsia conorii is sufficient to mediate adherence to and invasion of cultured mammalian cells. Infection and Immunity 2009, 77:5272-5280.
18. Renesto P., Samson L., Ogata H., Azza S., Fourquet P., Gorvel J-P., et al. Identification of two putative rickettsial adhesins by proteomic analysis. Research in Microbiology 2006, 157:605-612.
19. Vellaiswamy M., Kowalczewska M., Merhej V., Nappez C., Vincentelli R., Renesto P., et al. Characterization of rickettsial adhesin Adr2 belonging to a new group of adhesins in α-proteobacteria. Microbial Pathogenesis 2011, 50:233-242.
20. Anderson B., McDonald G., Jones D., Regnery R. A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near-identical sequences. Infection and Immunity 1990, 58:2760-2769.
21. Hackstadt T., Messer R., Cieplak W., Peacock M. Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing. Infection and Immunity 1992, 60:159-165.
22. Qi Y., Xiong X., Duan C., Jiao J., Gong W., Wen B. Recombinant protein YbgF induces protective immunity against Rickettsia heilongjiangensis infection in C3H/HeN mice. Vaccine 2013.
23. Ammerman N.C., Beier-Sexton M., Azad A.F. Laboratory maintenance of Rickettsia rickettsii. Current Protocols in Microbiology 2008, [chapter 3:Unit 3A 5].
24. Qi Y., Xiong X., Wang X., Duan C., Jia Y., Jiao J., et al. Proteome analysis and serological characterization of surface-exposed proteins of Rickettsia heilongjiangensis. PLoS ONE 2013, 8:e70440.
25. Xiong X., Wang X., Wen B., Graves S., Stenos J. Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches. BMC Microbiology 2012, 12:35.
26. Niu D.S.C.M., Wen B.H., Li Q.F., Qiu L., Zhang J.B. Development of quantitative PCR specific for Ricekttsia rickettsii. Chinese Journal of Epidemiology 2006, 6:526-529.
27. Kruisbeek A.M. Isolation of mouse mononuclear cells. Current Protocols in Immunology 2001, [chapter 3.1:Unit 3.1].
28. McDonald G.A., Anacker R.L., Garjian K. Cloned gene of Rickettsia rickettsii surface antigen: candidate vaccine for Rocky Mountain spotted fever. Science 1987, 235:83-85.
29. Crocquet-Valdes P., Diaz-Montero C., Feng H., Li H., Barrett A., Walker D. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine 2001, 20:979-988.
30. Feng H-M., Whitworth T., Olano J.P., Popov V.L., Walker D.H. Fc-dependent polyclonal antibodies and antibodies to outer membrane proteins A and B, but not to lipopolysaccharide, protect SCID mice against fatal Rickettsia conorii infection. Infection and Immunity 2004, 72:2222-2228.
31. Chan Y.G-Y., Riley S.P., Chen E., Martinez J.J. Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B. Infection and Immunity 2011, 79:2303-2313.
32. Mcdonald G.A., Anacker R.L., Mann R.E., Milch L.J. Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii. Journal of Infectious Diseases 1988, 158:228-231.
33. Neuberger M.S., Rajewsky K. Activation of mouse complement by monoclonal mouse antibodies. European Journal of Immunology 1981, 11:1012-1016.
34. Gessner J., Heiken H., Tamm A., Schmidt R. The IgG Fc receptor family. Annals of Hematology 1998, 76:231-248.
35. Unkeless J., Eisen H.N. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages. Journal of Experimental Medicine 1975, 142:1520-1533.
36. Kipps T.J., Parham P., Punt J., Herzenberg L. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. Journal of Experimental Medicine 1985, 161:1-17.
37. Takai T., Li M., Sylvestre D., Clynes R., Ravetch J.V. FcR γ-chain deletion results in pleiotrophic effector cell defects. Cell 1994, 76:519-529.
38. Feng H-M., Whitworth T., Popov V., Walker D.H. Effect of antibody on the rickettsia-host cell interaction. Infection and Immunity 2004, 72:3524-3530.
39. Feng H-M., Walker D.H. Mechanisms of intracellular killing of Rickettsia conorii in infected human endothelial cells, hepatocytes, and macrophages. Infection and Immunity 2000, 68:6729-6736.
40. Huber V.C., McKeon R.M., Brackin M.N., Miller L.A., Keating R., Brown S.A., et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clinical and Vaccine Immunology 2006, 13:981-990.
41. Jerrells T.R., Jarboe D.L., Eisemann C.S. Cross-reactive lymphocyte responses and protective immunity against other spotted fever group rickettsiae in mice immunized with Rickettsia conorii. Infection and Immunity 1986, 51:832-837.
42. Feng H-m Popov V.L., Yuoh G., Walker D.H. Role of T lymphocyte subsets in immunity to spotted fever group Rickettsiae. Journal of Immunology 1997, 158:5314-5320.
43. Crocquet-Valdes P.A., Thirumalapura N.R., Ismail N., Yu X., Saito T.B., Stevenson H.L., et al. Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of Ehrlichiosis. Clinical and Vaccine Immunology 2011, 18:2018-2025.
44. Walker D.H., Olano J.P., Feng H-M. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infection and Immunity 2001, 69:1841-1846.
45. Zaiss D.M., Sijts A.J., Mosmann T.R. Enumeration of cytotoxic CD8T cells ex vivo during the response to Listeria monocytogenes infection. Infection and Immunity 2008, 76:4609-4614.
46. Huang H., Hao S., Li F., Ye Z., Yang J., Xiang J. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes. Immunology 2007, 120:148-159.
47. Feng H-M., Popov V.L., Walker D.H. Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infection and Immunity 1994, 62:1952-1960.
48. de Sousa R., Ismail N., Dória N.S., França A., Amaro M., Anes M., et al. Intralesional expression of mRNA of interferon-γ, tumor necrosis factor-α, interleukin-10, nitric oxide synthase, indoleamine-2, 3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. Journal of Infectious Diseases 2007, 196:770-781.
49. Feng H., Walker D.H. Interferon-gamma and tumor necrosis factor-alpha exert their antirickettsial effect via induction of synthesis of nitric oxide. American Journal of Pathology 1993, 143:1016.